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In this paper we report DNA binding of butadiene monoepoxide, a first metabolite of 1,3-butadiene
catalyzed by monooxygenases. We prepared alkylated purines as marker compounds for
32P-postlabeling and electrochemical analysis and developed methods to measure the
corresponding products. The traditional postlabeling assay was modified by incorporating a solid
phase extraction column and high-performance liquid chromatography (HPLC) enrichment steps
to the assay prior to labeling. The final analysis of adducted N6 adenines is based on two
dimensional thin-layer chromatography (TLC) and an on-line HPLC/radioactivity analysis. The
qualitative and quantitative results are based on positively identified marker compounds.
Alkylated N7 guanines were released from DNA by neutral thermal hydrolysis, prepurified by
HPLC, and analyzed by HPLC with a sensitive electrochemical detection procedure. By using
these methods, we found alkylation of calf thymus DNA exposed to butadiene monoepoxide in
vitro at adenine N6 and guanine N7 sites. Analysis of lung DNA samples from mice and rats
exposed to butadiene through inhalation showed that adenine N6 adducts were formed in vivo in
a dose responsive manner. Environ Health Perspect 104(Suppl 3):655-657 (1996)
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Introduction
1,3-Butadiene (BD) is not only a high pro-
duction volume chemical for the polymer
industry but is also a common environ-
mental contaminant. It has been estimated
that most environmental BD emissions
derive from mobile sources. Burning of
organic material produces emissions
containing low concentrations of BD.
Exposure to low concentrations of BD is
thus a common characteristic of the entire
human population (1).
Long-term inhalation studies indicate
that BD is a multisite carcinogen in mice
and rats, mice being by far the more sensi-
tive species (2). A recent epidemiological
study in the BD industry indicates an ele-
vated mortality of lymphatic and reticular
sarcoma among the production workers (3).
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Small alkylating agents react mainly
with the N7 position ofguanine, but other
alkylation sites in DNA are also detected
in vitro (4,5). Goodrow et. al (6) have
reported activation ofthe K-rasprotoonco-
gene at codon 13 involving a mutation in
guanine. Butadiene monoepoxide (BMO),
one of the reactive metabolites of BD, has
been reported to alkylate guanine at the
N7 position, but poor stability and low
labeling efficiency ofthe product limits its
use in postlabeling analyses (7,8). In an
inhalation study in which transgenic mice
were exposed to BD, an elevated level ofA
to T transversions were observed in the lad
gene (9). Although the alkylation at ade-
nine may be a minor reaction site in DNA,
this observation makes adenine an interest-
ing alternative in DNA adduct monitoring.
In this paper we report alkylation of
both adenine and guanine derived from
BMO in relation to in vitro exposure to
BMO or in vivoexposure to BD.
Materials and Methods
All commercial chemicals used in this
study were ofanalytical grade. Adenine N6
adducts ofBMO were prepared by reacting
deoxyadenosine with 3' and 5'-deoxy-
adenosine monophosphates in alkaline
conditions. The products formed were
purified chromatographically and charac-
terized by ultraviolet spectroscopy (UV),
nuclear magnetic resonance (NMR), and
mass spectrometry (MS) (10,11). Guanine
N7 adducts were prepared and analyzed as
described by Neagu et al. (7). The struc-
tures of the compounds studied are shown
in Figure 1.
Calf thymus DNA (1 mg/ml) was
exposed to BMO (10 pl/ml) for 1 and 6 hr.
BMO was evaporated from the samples
and the samples were subjected to enzyme-
mediated digestion or thermal hydrolysis.
Rats and mice were exposed to BD
for 5 days, 6 hr/day (50, 200, 500 ppm).
DNA for N6 adduct analysis was isolated
using a phenol extraction procedure (12).
For the postlabeling analysis, an aliquot of
DNA was taken and digested to 3' nucleo-
tides with micrococcal nuclease and spleen
phosphodiesterase. BMO alkylated 2'-
deoxyadenosine-3'-monophosphates were
first enriched with disposable solid phase
extraction cartridges (octadecylsilane
phase). Normal nucleotides (NNs) were
washed out from the column with 50 mM
ammonium formate (AF) containing 3%
methanol, pH 4. The amount of DNA
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digested was measured from the normal
nucleotides by HPLC. N6 alkylated
adenine adducts were eluted with 50%
water/methanol.
Adduct enrichment was performed
with reversed-phase HPLC. A fraction was
collected from 17 to 20 min (residual NNs
had the following retention times: 2'-de-
oxycytidine-3'-monophosphate, 4.3 min;
2'-deoxyguanosine-3'-monophosphate, 5.0
min; 2'-deoxythymidine-3'-monophos-
phate, 6.6 min; 2'-deoxyadenosine-3'-
monophosphate, 7.7 min). Enriched
adducts were postlabeled to 5' position by
T4 kinase; the formed bisphosphates were
treated with nuclease P1 resulting in 5'
monophosphate adducts. The samples
were spiked with the corresponding 5'
compound and separated by two dimen-
sional TLC chromatography. Dimension 1
was 0.3 M AF and dimension 2 was done
with isobutyric acid/ammonia/water eluent
in a ratio 69/1/30.
The adducts were located on TLC
plates with autoradiography (Figure 2);
the spot was scraped and consequently
extracted with IM AF. The ultimate
analysis was carried out on a reversed-
phase HPLC equipped with UV and
radioactivity detectors. The HPLC gradi-
ent was 3% acetonitrile maintained for 5
min followed by a linear gradient to 16%
during 26 min. The buffer was 0.75M AF
and the ratio of scintillation solvent to
HPLC effluent was 4:1.
Results and Discussion
We applied a solid phase extraction (SPE)
procedure as a first step in our analytical
protocol. The alkylated N6 products were
retained in the cartridge and the normal
nucleotides were washed out. The SPE step
was necessary to avoid column loading
caused by NNs in preparative HPLC. If
severe column loading occurs, NNs may
interfere with the postlabeling analysis.
By carrying out an ion exchange TLC
and a reversed-phase HPLC, the analysis
used two different retention mechanisms,
which improved the qualitative reliability
ofthe analysis. From a quantitative point
ofview, the use of a HPLC/radioactivity
detector decreases the detection limit by
the factor of 3 when compared to tradi-
tional scintillation counting. However,
the standard deviation is much less
pronounced if the analysis is carried out
using the HPLC/radioactivity detector
(SD ±4%; n=3) instead ofthe commonly
used Cherenkov counting technique
(SD ±23%; n=3).
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Figure 1. Structures of butadiene monoxide purine adducts studied. Cl and C2 refer to the carbon involved in the
covalent bond formation.
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Figure 2. Two dimensional TLC (A) and a relative map position (B) of normal nucleotides to N6 alkylated
2'-deoxyadenosine-3'-monophosphate. Abbreviations: dCMP, 2'-deoxycytidine-3'-monophosphate; dGMP,
2'-deoxyguanosine-3'-monophosphate; dTMP, 2'-deoxythymidine-3'-monophosphate; dAMP, 2'-deoxyadenosine-
3'-monophosphate.
When calfthymus DNA was exposed
to BMO for 1 and 6 hr, five times more
adducts (both N7 and N6) were observed
with the longer time exposure. The
amount of N7 alkylated guanines was
about 300 times higher than the amount of
N6 products; however, the stability ofthe
product was shown to be very different. As
reported by Neagu et. al. (7), the N7 prod-
ucts showed a halflife of48 hr, but the N6
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products were stable and showed no
decrease in the adduct levels within the 2-
week period studied. This fact may favor
the use of N6 adducts in future biomoni-
toring applications because the N6 adducts
of adenine are able to reflect cumulative
effects from long-term exposure.
Two dimensional TLC by itself was
not able to resolve all of the interfering
products present in the in vivo samples. By
combining a subsequent HPLC analysis
with a radioactivity detector, the selectivity
ofthe analysis was much improved (Figure
3). In the lung samples of the rats and
mice exposed by inhalation to BD (Figure
4), a dose-response increase of the N6
adenine alkylation by BMO was detected.
Insignificant differences were seen between
the species, the lung tissue ofmouse being
only very weakly more sensitive than the
rat lung to the BMO-derived N6 adenine
adduct formation. At the lowest exposure
level (50 ppm) no differences were seen in
the adduct levels when compared to the
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Figure 3. HPLC chromatogram of a mouse lung
sample. The signal was measured on-line as counts
using a radioactivity detector. The arrow indicates the
N6 alkylation product
control animals in both species. This is
mainly due to the nonspecific radioactivity
detected close to the monitored product.
Work is ongoing to further lower the
background level observed in the in vivo
samples. We are also in the process of
analyzing the N7 adducts of guanine in
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Figure 4. The amount of N6 alkylated adenines found
in lung samples of mice and rats exposed through
inhalation to 1,3-butadiene at various concentrations.
dAMP, 2'-deoxyadenosine-3'-monophosphate. (Three
animals of each species per concentration were
analyzed in triplicate.)
the corresponding lung samples from
which the N6 adducts of adenine are
now reported.
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